NationNews
  • e-paper
    • e-paper
    • e-magazines
  • News
  • Regional
  • Elections
  • Sports
  • World
  • Entertainment
  • classifieds
  • Multimedia
    • Multimedia
    • Podcasts
  • all sections
    • Business
    • Life Style
    • Family Notices
    • Commentary
    • Ticketnation
    • RSS
    • e-publications
    • Politics
    • Contact US
    • Smart Homes
    • Workbook
    • Feature: Owen S Arthur
  • Print Subscription
    • e-paper
      • e-paper
      • e-magazines
    • News
    • Regional
    • Elections
    • Sports
    • World
    • Entertainment
    • classifieds
    • Multimedia
      • Multimedia
      • Podcasts
    • all sections
      • Business
      • Life Style
      • Family Notices
      • Commentary
      • Ticketnation
      • RSS
      • e-publications
      • Politics
      • Contact US
      • Smart Homes
      • Workbook
      • Feature: Owen S Arthur
    • Print Subscription
WHO
World
 on May 26, 2020

WHO suspends testing malaria drug in COVID-19 patients

Article by  

GENEVA – The World Health Organisation (WHO) has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, Director General Tedros Adhanom Ghebreyesus said on Monday.

Hydroxycholoroquine has been touted by Donald Trump and others as a possible treatment for the disease caused by the novel coronavirus. The U.S. President has said he was taking the drug to help prevent infection.

“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” Tedros told an online briefing.

He said the other arms of the trial – a major international initiative to hold clinical tests of potential treatments for the virus – were continuing.

The WHO has previously recommended against using hydroxychloroquine to treat or prevent coronavirus infections, except as part of clinical trials.

Dr Mike Ryan, head of the WHO emergencies programme, said the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution”. (Reuters)

Comments are closed.

Cartoon
Facebook
@ Follow me
Tweets
NationNews
Site Index
  • Home
  • News
  • Business
  • Sports
  • Commentary
  • Entertainment
  • Lifestyle
  • Regional
  • World
  • E-Paper
  • Multimedia
  • Blogs
  • Home
  • News
  • Business
  • Sports
  • Commentary
  • Entertainment
  • Lifestyle
  • Regional
  • World
  • E-Paper
  • Multimedia
  • Blogs
Services
For information about this website or content published please contact the Webmaster or Online Editor, respectively. Regarding press releases please contact the News Room.
Subscribe
Subscribe to NationNews with our Webfeed. Follow us on Facebook and Twitter.
General Info
  • Home
  • News
  • Business
  • Sports
  • Commentary
  • Entertainment
  • Lifestyle
  • Regional
  • World
  • E-Paper
  • Multimedia
  • Blogs
  • Home
  • News
  • Business
  • Sports
  • Commentary
  • Entertainment
  • Lifestyle
  • Regional
  • World
  • E-Paper
  • Multimedia
  • Blogs
Legal
Copyright © 1997 - , Nation Publishing Co. Limited • P.O. Box 1203, Fontabelle, St. Michael, BB11000, Barbados, West Indies • All Rights Reserved No unauthorized use is permitted of content produced by NationNews.com, The Nation Newspaper or any other publication or media owned by Nation Publishing Co. Limited. Unauthorized use includes framing and direct posting of content on websites other than www.nationnews.com.